BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21186938)

  • 1. Symptomatic calcification of a thyroid lobe and surrounding tissue after radioactive iodine treatment to ablate the lobe.
    Kim JH; Park JH; Kim SY; Bae HY
    Thyroid; 2011 Feb; 21(2):203-5. PubMed ID: 21186938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioactive iodine lobe ablation as an alternative to completion thyroidectomy for follicular carcinoma of the thyroid.
    Randolph GW; Daniels GH
    Thyroid; 2002 Nov; 12(11):989-96. PubMed ID: 12490076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.
    Bal CS; Kumar A; Pant GS
    Nucl Med Commun; 2003 Feb; 24(2):203-8. PubMed ID: 12548045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospective therapy study in differentiated thyroid carcinoma].
    Gemsenjäger E; Heitz P; Martina B
    Schweiz Med Wochenschr; 1995 Nov; 125(46):2226-36. PubMed ID: 8525342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid lobe ablation with radioactive iodine as an alternative to completion thyroidectomy after hemithyroidectomy in patients with follicular thyroid carcinoma: long-term follow-up.
    Barbesino G; Goldfarb M; Parangi S; Yang J; Ross DS; Daniels GH
    Thyroid; 2012 Apr; 22(4):369-76. PubMed ID: 22385290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large remnant 131I ablation as an alternative to completion/total thyroidectomy in the treatment of well-differentiated thyroid cancer.
    Leblanc G; Tabah R; Liberman M; Sampalis J; Younan R; How J
    Surgery; 2004 Dec; 136(6):1275-80. PubMed ID: 15657587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiated thyroid cancer: lobectomy and radioiodine, a treatment suitable for all cases?
    Allan E; Owens SE; Waller ML
    Nucl Med Commun; 1999 Nov; 20(11):983-9. PubMed ID: 10572907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients.
    Bal CS; Kumar A; Pant GS
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1666-73. PubMed ID: 15070929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the efficacy of iodine-131 for thyroid ablation.
    Comtois R; Thériault C; Del Vecchio P
    J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of follicular and Hürthle cell neoplasms of the thyroid gland.
    McHenry CR; Sandoval BA
    Surg Oncol Clin N Am; 1998 Oct; 7(4):893-910. PubMed ID: 9735140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of coexisting thyrotropin/growth-hormone-secreting pituitary adenoma and papillary thyroid carcinoma: a therapeutic challenge.
    Nguyen HD; Galitz MS; Mai VQ; Clyde PW; Glister BC; Shakir MK
    Thyroid; 2010 Jan; 20(1):99-103. PubMed ID: 20067380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Completion thyroidectomy: a critical appraisal.
    Shaha AR; Jaffe BM
    Surgery; 1992 Dec; 112(6):1148-52; discussion 1152-3. PubMed ID: 1455317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endobronchial mass developing 19 years after total thyroidectomy due to follicular thyroid carcinoma.
    Yeo CD; Kang JY; Kang HH; Lee SH; Kim JW
    Intern Med; 2012; 51(4):401-3. PubMed ID: 22333377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hürthle cell carcinoma: a clinicopathological study of thirteen cases.
    Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G
    Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary metastases from follicular thyroid carcinoma.
    Prodam F; Pagano L; Belcastro S; Golisano G; Busti A; Samà M; Caputo M; Bellone S; Voci A; Valente G; Aimaretti G
    Thyroid; 2010 Jul; 20(7):823-30. PubMed ID: 20604687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
    Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
    J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.
    Byeon HK; Ban MJ; Lee JM; Ha JG; Kim ES; Koh YW; Choi EC
    Ann Surg Oncol; 2012 Dec; 19(13):4259-61. PubMed ID: 23070784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy concept in differentiated thyroid gland carcinoma--results of 25 years with 257 patients].
    Gemsenjäger E; Heitz PU; Martina B; Schweizer I
    Praxis (Bern 1994); 2000 Nov; 89(44):1779-97. PubMed ID: 11109916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metastasis of differentiated follicular thyroid carcinoma to the ciliary body].
    Lommatzsch PK
    Klin Monbl Augenheilkd; 1994 Nov; 205(5):309-13. PubMed ID: 7844948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
    Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
    Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.